Editorial board

Senior Editor

Theresa A Zesiewicz, University of South Florida, FL, USA Dag Aarsland, King's College London, UK

Editorial Board

Dag Aarsland, King's College London, UK
Ammar Al-Chalabi, King's College London, UK
Quincy J Almeida, Wilfrid Laurier University, Canada
James P Bennett, Jr, Neurodegeneration Therapeutics, Inc., VA, USA
Henry Brodaty, University of New South Wales, Australia
John Collinge,UCL Institute of Neurology, UK
Bradford D Dickerson, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Alessandro Di Rocco, Northwell Health, NY, USA
Tzvi Dwolatzky, Rambam Medical Center, Israel
James E Galvin, Florida Atlantic University, FL, USA
Donald Grosset, University of Glasgow, UK
John Hardy,UCL Institute of Neurology, UK
Nobutaka Hattori, Juntendo University School of Medicine, Japan
Aleksey Kazantsev, Harvard Medical School, MA, USA
Martin Knapp, London School of Economics and Political Science, UK
Tom Mercer,Queen Margaret University, UK
Erwin B Montgomery, Greenville Neuromodulation Center, PA, USA
Karen E Morrison, University of Southampton, UK
M. Maral Mouradian, Rutgers University – Robert Wood Johnson Medical School, NJ, USA
Ronald C Petersen, Mayo Clinic, MN, USA
Olivier Piguet, University of Sydney, Australia
Werner Poewe, Medical University Innsbruck, Austria
Pamela Shaw, University of Sheffield, UK
Hilkka Soininen, University of Eastern Finland, Finland
Till Sprenger, DKD Helios Klinik Wiesbaden, Germany
Jon Stamford, Cure Parkinson's Trust, UK
Eduard Tolosa, Universitat de Barcelona, Spain
Joe Verghese, Albert Einstein College of Medicine, NY, USA
Nicholas W Wood, UCL Institute of Neurology, UK